Send feedback

MCPH1 p.Ser765Trp

c.2294C>G · rs200820759 · VCV363562

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
AlphaMissense
likely pathogenic
0.5918 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0247%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
2
Inborn genetic diseases

⚠ Built without this gene's context — gene constraint and dosage, protein structure, pathways, panels and related-variant links were not looked up for this page. why

Computational evidence

Protein change
AlphaMissense0.5918likely pathogenic
REVEL0.429indeterminate
SaProtLLR -14.48damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate.
Splicing
SpliceAI—not looked up on this page · why
Constraint at this position
ConservationphyloP 1.6GERP 1.1, phastCons 0.002
Regional constrainto/e 1.49unconstrained · MANE · 236 kb · p 2.4e-54 · regional, not allelic
Overall
CADD22.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0247% European (non-Finnish) · 292/1,180,042 alleles
Filtering AF 0.0224% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0215%
Overall 0.0211% 341/1,614,218 alleles · ultra-rare exomes 300/1,461,856 · genomes 41/152,362 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0281% 3,557
European (non-Finnish)grpmax 0.0247% 4,041
African / African-American 0.0213% 4,692
Ashkenazi Jewishnot grpmax-eligible 0.0203% 4,935
Remaining individualsnot grpmax-eligible 0.0144% 6,945

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MCPH1
Protein
p.Ser765Trp
Coding
c.2294C>G
MANE Select
NM_024596
dbSNP
rs200820759
Type
single nucleotide variant
Location
chr8:6621533 (GRCh38)
Full MCPH1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mcph1-p-ser765trp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown